AstraZeneca and Eccogene are advancing ECC5004, a once-daily GLP-1 receptor agonist pill. Early stage trial showed a promising weight-loss signal and a favorable safety profile, with mid stage trials ...

LOS ANGELES (Reuters) -Paramount's new chairman and chief executive, David Ellison, outlined a plan to transform the century-old entertainment company into a technology-driven media enterprise in an ...

(Reuters) -U.S. President Donald Trump on Thursday demanded the immediate resignation of new Intel CEO Lip-Bu Tan, calling ...

Shares of Manulife have lost about 5% this year. They were down 3.5% on Thursday. "That (the U.S. results) overshadowed what ...

A weak July jobs report and massive downward revisions show it is getting harder to find a job – and the ones available exist ...

Founded in 2015, Lyten started out in a shipping container in California, but has gained backing from Chrysler-parent ...

Firefly, which became the first private enterprise to achieve a successful lunar landing five months ago, raised $868.3 ...

(Reuters) -Americans' longer-term inflation outlook deteriorated in July even as households boosted their views on the ...

Amit Agarwal, finance chief of top Indian garment maker Raymond, said he was pinning hopes on the company's one factory in ...

(Reuters) -Apple said on Wednesday that Samsung Electronics will supply chips from its production plant in Austin, Texas, for ...

STOCKHOLM (Reuters) -U.S. battery startup Lyten has agreed to buy most of bankrupt Swedish battery maker Northvolt, it said ...

The company's quarterly Permian natural gas inlet volumes rose about 11% to a record 6.28 billion cubic feet per day from a ...